Sessions and Speakers
9:30-18:00 June 5th, 2018. The Royal Academy of Engineering
08:30 - 09:30
Registration and Coffee
09:30 - 10:30
Welcome: The UK Landscape for Synthetic Biology
Prof Richard Kitney and Prof Paul Freemont, Co-Directors, SynbiCITE
Introduction: The UK Bioeconomy
Rt Hon. Lord David Willetts, MP
10:30 - 11:15
Sustaining the future of engineering biology in the UK
Session 1 - Panel Discussion:
Policy, practical requirements, and commercialisation strategies that are needed to deliver the vision of building a successful synthetic biology industry in the UK
Chair: Rt Hon. Lord David
Willetts, MP
11:15 - 11:30
Coffee Break
11:30 - 12:30
Showcasing the future of engineering biology in the UK: today’s innovation shaping tomorrow
Session 2 - Company Showcase:
UK Companies applying engineering biology to solve important issues confronting society – showcasing their technology, journey and future
Chair: Prof Richard Kitney, Co-Director, SynbiCITE
Presenting Companies:
Synpromics - Michael Roberts, Founder and CSO
Customem - Ben Reeve, CTO
Prokarium - Rocky Cranenburgh, CSO
Prozomix - Simon Charnock, Managing Director / Technical Director
12:30 - 13:15
Innovation and scale up: global company showcase
Session 3 - Company Showcase:
The fundamental technologies improving health care, optimising automation, and reducing waste
Chair: Prof Paul Freemont, Co-Director, SynbiCITE
Presenting Companies:
GSK - David Tew, Technical Project Lead, Biological Technologies
CyBio - Chris Hirst, Application Development Scientist
Singer Instruments - Harry Singer, Singer Instruments
More companies to be announced soon
13:15-13:45
Lunch
13:45 – 14:30
Strategic Policies – Catalysts for better outcomes
Session 4 - Panel Discussion:
Why supporting "game changing" science and engineering is critical to UK economic success
Chair: Lionel Clarke, Co-Chair, Synthetic Biology Leadership Council
14:30 – 15:30
Engineering biology game changers – AI, Gene Editing, Lab Automation and DNA Storage
Session 5 - Company Showcase:
Transformative applications and collaborations driving the UK’s engineering biology industry forward
Chair: Prof Richard Kitney, SynbiCITE
Presenting companies:
LabGenius - James Field, CEO and Founder
Microsoft - Andrew Phillips, Head of Bio Computation group
Synthace - Tim Fell, CEO
Desktop Genetics - Victor Dillard, COO and Founder
15:30-15:45
Coffee Break
15:45 – 16:30
Investing in Transformative Technologies
Session 6 - Panel Discussion:
Global investment, matching entrepreneurs and investment, and keeping talent in the UK
Chair: Malcolm Glaister, CEO, Eight Great Technologies
16:30 – 17:00
Maintaining and advancing the foundation of synthetic biology research and innovation in the UK
Session 7 - Panel Discussion:
The skills, training, and resources needed to sustain engineering biology in the UK
Chairs: Prof Richard Kitney and Prof Paul Freemont, Co-Directors, SynbiCITE
17:00-17:15
Closing Address
17:15-18:00
Networking Reception
Sponsored by